About Mohammad Saad Alam
Form D filings for Time Therapeutics from 2018 to 2024 list Mohammad Saad Alam as CEO and director.
Mohammad Saad Alam first appears on SEC filings in 2018.
Experience
This experience comes from SEC filings. The years are when the filings name Mohammad Saad Alam in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Mohammad Saad Alam works with at each company, as listed on that company's latest Form D.
Time Therapeutics Inc. · Form D, Jul 2, 2024
SB
Stuart Blitz
Executive officer and director
TM
Theodore Maidenberg
Director